27 results on '"Horwitz P"'
Search Results
2. Revisiting a single day salvage conditioning following graft failure
3. Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
4. Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation
5. Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
6. High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
7. Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma
8. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children
9. Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study
10. Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
11. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
12. A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up
13. Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors
14. Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
15. Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
16. Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
17. Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
18. A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs
19. Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3–6/6 HLA matched donors
20. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
21. Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
22. Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia
23. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen
24. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism
25. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome
26. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria
27. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.